Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
0.8199
Dollar change
+0.0998
Percentage change
13.86
%
Index- P/E- EPS (ttm)-0.46 Insider Own1.66% Shs Outstand50.58M Perf Week24.43%
Market Cap41.47M Forward P/E- EPS next Y-0.33 Insider Trans0.00% Shs Float49.75M Perf Month24.47%
Income-21.47M PEG- EPS next Q-0.12 Inst Own9.87% Short Float0.13% Perf Quarter-6.81%
Sales9.19M P/S4.51 EPS this Y19.23% Inst Trans-10.59% Short Ratio0.56 Perf Half Y37.59%
Book/sh0.16 P/B5.01 EPS next Y21.43% ROA-44.61% Short Interest0.06M Perf Year26.16%
Cash/sh0.53 P/C1.56 EPS next 5Y- ROE-141.36% 52W Range0.45 - 1.44 Perf YTD-2.39%
Dividend Est.- P/FCF- EPS past 5Y8.30% ROI-250.39% 52W High-43.06% Beta1.40
Dividend TTM- Quick Ratio4.94 Sales past 5Y57.49% Gross Margin52.97% 52W Low82.12% ATR (14)0.06
Dividend Ex-Date- Current Ratio5.06 EPS Y/Y TTM17.76% Oper. Margin-470.00% RSI (14)67.57 Volatility14.00% 7.60%
Employees142 Debt/Eq0.12 Sales Y/Y TTM341.99% Profit Margin-233.66% Recom1.00 Target Price2.42
Option/ShortYes / Yes LT Debt/Eq0.03 EPS Q/Q49.50% Payout- Rel Volume0.61 Prev Close0.72
Sales Surprise24.15% EPS Surprise15.79% Sales Q/Q553.67% EarningsMay 23 BMO Avg Volume112.26K Price0.82
SMA2018.40% SMA5013.79% SMA20013.61% Trades Volume67,971 Change13.86%
Date Action Analyst Rating Change Price Target Change
Oct-08-21Initiated ROTH Capital Buy $7
Jul-29-21Initiated Aegis Capital Buy $10
Dec-01-20Initiated Cantor Fitzgerald Overweight $9
Dec-16-13Initiated Oppenheimer Outperform $26
May-23-24 11:52AM
11:00AM
07:00AM
May-21-24 07:03AM
May-09-24 07:00AM
07:00AM Loading…
Apr-16-24 07:00AM
Apr-11-24 07:00AM
Apr-02-24 07:00AM
Mar-28-24 09:00AM
Mar-20-24 09:00AM
Mar-19-24 09:00AM
Mar-13-24 09:00AM
Mar-07-24 12:53PM
09:20AM
07:00AM
07:00AM Loading…
Mar-06-24 07:00AM
Mar-05-24 07:00AM
Feb-28-24 07:00AM
Feb-26-24 07:00AM
Feb-22-24 07:00AM
Feb-21-24 07:00AM
Feb-20-24 07:00AM
Feb-06-24 07:08AM
Jan-23-24 07:00AM
Jan-17-24 07:00AM
Jan-12-24 12:00PM
Dec-21-23 07:00AM
Dec-19-23 07:00AM
Dec-05-23 07:00AM
Nov-28-23 07:00AM
09:57AM Loading…
Nov-16-23 09:57AM
Nov-15-23 07:00AM
Nov-08-23 07:00AM
Nov-02-23 07:00AM
Oct-31-23 07:00AM
Oct-18-23 07:00AM
Sep-27-23 07:00AM
Aug-17-23 07:00AM
Aug-15-23 07:00AM
Aug-01-23 07:00AM
Jul-25-23 07:00AM
Jul-19-23 07:00AM
Jul-17-23 08:15AM
07:30AM
Jul-12-23 07:00AM
Jul-03-23 07:00AM
Jun-22-23 05:50PM
Jun-21-23 07:00AM
May-24-23 07:00AM
May-18-23 07:00AM
May-09-23 07:00AM
May-04-23 07:00AM
May-02-23 07:00AM
Apr-28-23 09:00AM
Apr-27-23 07:00AM
Mar-30-23 04:01PM
Mar-29-23 07:00AM
Mar-21-23 01:45PM
Mar-15-23 08:00AM
Mar-13-23 01:56AM
Mar-09-23 07:00AM
Mar-06-23 07:00AM
06:55AM
Mar-01-23 04:01PM
07:00AM
Feb-28-23 07:00AM
Feb-27-23 08:00AM
Feb-21-23 07:00AM
Jan-24-23 07:00AM
Jan-19-23 07:00AM
Dec-28-22 07:00AM
Dec-21-22 06:00AM
Dec-08-22 07:00AM
Nov-17-22 08:25AM
07:00AM
Nov-15-22 07:00AM
Nov-14-22 08:00AM
Nov-07-22 07:00AM
Oct-12-22 06:00AM
Oct-06-22 07:00AM
Sep-21-22 07:00AM
Sep-14-22 07:00AM
Sep-13-22 07:00AM
Sep-07-22 07:15AM
Aug-31-22 08:25AM
07:00AM
Aug-25-22 08:22AM
Aug-17-22 01:18PM
Aug-02-22 07:00AM
Jul-28-22 07:30AM
Jul-26-22 07:00AM
Jul-11-22 07:00AM
Jul-05-22 07:00AM
Jun-15-22 07:41AM
May-26-22 08:25AM
07:00AM
May-23-22 07:00AM
May-16-22 07:00AM
May-11-22 07:00AM
May-10-22 07:00AM
Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, Industrial Applications, and Human Health. The Agriculture segment develops seed traits, agrochemical products, and agro biological products to improve plant performance. The Industrial Applications focuses on the development and commercialization of improved castor bean seeds for industrial uses. The Human Health segment involves discovery and development of human microbiome-based therapeutics. The company was founded by Amir Barzilay and Hagai Karchi on October 10, 1999 and is headquartered in Rehovot, Israel.